Increased xanthine oxidase in the thalamus and putamen in depression

World Journal of Biological Psychiatry

Volumn 11, Issue 2 PART 2, 2010, Pages 314-320

  Michel, Tanja Maria ^a,b,c   Camara, Sybille ^a   Tatschner, Thomas ^a   Frangou, Sophia ^c   Sheldrick, Abigail Jane ^b   Riederer, Peter ^a   Grünblatt, Edna ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Depression; Limbic system; Oxidative stress; Putamen; Xanthine oxidase

Indexed keywords

XANTHINE OXIDASE;

ARTICLE; BRAIN HOMOGENATE; CAUDATE NUCLEUS; COMPARATIVE STUDY; DEPRESSION; ENTORHINAL CORTEX; ENZYME ACTIVITY; HUMAN; PUTAMEN; THALAMUS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN; DEPRESSIVE DISORDER; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PUTAMEN; REGRESSION ANALYSIS; SEX FACTORS; STATISTICS, NONPARAMETRIC; THALAMUS; XANTHINE OXIDASE;

EID: 77950826169     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970802123695     Document Type: Article

References (74)

1. Akaike T, Ando M, Oda T, Doi T, Ijiri S, Araki S, et al. 1990. Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest 85:739-745. (Pubitemid 20087476)
2. Aranda R, Doménech E, Rus AD, Real JT, Sastre J, Viña J, et al. 2007. Age-related increase in xanthine oxidase activity in human plasma and rat tissues. Free Radic Res 28:1-6. (Pubitemid 350090773)
3. Baumann B, Danos P, Krell D, Diekmann S, Leschinger A, Stauch R, et al. 1999. Reduced volume of limbic systemaffiliated basal ganglia in mood disorders: preliminary data from a post-mortem study. J Neuropsychiatry Clin Neurosci 11:1-78. (Pubitemid 29070667)
4. Berry CE, Hare JM. 2004. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555:589-606. (Pubitemid 38404582)
5. Bilici M, Efe H, Köroǧlu MA, Uydu HA, Bekaroǧlu M, Deǧer O. 2001. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64:43-51. (Pubitemid 32268670)
6. Brown JL, Terada LS, Grosso MA, Whitmann GJ, Velasco SE, Patt A, et al. 1988. Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts. J Clin Invest 81:1297-1301.
7. Caetano SC, Sassi R, Brambilla P, Harenski K, Nicoletti M, Mallinger AG, et al. 2001. MRI study of thalamic volumes in bipolar and unipolar patients and healthy individuals. Psychiatry Res 108:161-168. (Pubitemid 34072916)
8. Drevets WC. 2000. Neuroimaging studies of mood disorders. Biol Psychiatry 48:813-829.
9. Durany N, Münch G, Michel TM, Riederer P. 1999. Investigations on oxidative stress and therapeutical implications in dementia. Eur Arch Psychiatry Clin Neurosci 249:68-73. (Pubitemid 30011745)
10. Emmerson BT. 1967. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi. Australasian Ann Med 16:205-214.
11. Ende G, Demirakca T, Walter S, Wokrina T, Sartorius A, Wildgruber D, et al. 2006. Subcortical and medial temporal MR-detectable metabolite abnormalities in unipolar major depression. Eur Arch Psychiatry Clin Neurosci 257:36-39. (Pubitemid 46295182)
12. Fridovich I. 1986. Biological effects of the superoxide radical. Arch Biochem Biophys 247:1-11. (Pubitemid 16076916)
13. Germain A, Nofzinger EA, Kupfer DJ, Buysse DJ. 2004. Neurobiology of non-REM sleep in depression: further evidence for hypofrontality and thalamic dysregulation. Am J Psychiatry 161:1856-1863. (Pubitemid 39314680)
14. Götz ME, Kunig G, Riederer P, Youdim MB. 1994. Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 63:37-122. (Pubitemid 24250150)
15. Gok F, Ichida K, Topaloglu R. 2003. Mutational analysis of the xanthine dehydrogenase gene in a Turkish family with autosomal recessive classical xanthinuria. Nephrol Dial Transplant 18:2278-2283. (Pubitemid 37336814)
16. Grü nblatt E, Mandel S, Jacob-Hirsch J, Zeligson S, Amariglo N, Rechavi G, et al. 2004. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitinproteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm 111:1543-1573. (Pubitemid 40068786)
17. Grü nblatt E, Schlösser R, Fischer P, Fischer MO, Li J, Koutsilieri E, et al. 2005. Oxidative stress related markers in the "VITA" and the centenarian projects. Neurobiol Aging 26:429-438. (Pubitemid 40093926)
18. Gsell W, Lange KW, Pfeuffer R, Heckers S, Heinsen H, Senitz D, et al. 1993. How to run a brain bank. A report from the Austro-German brain bank. J Neural Transm Suppl 39:31-70. (Pubitemid 23216927)
19. Guerciolini R, Szumlanski C, Weinshilboum RM. 1998. Human liver xanthine oxidase: nature and extent of individual variation. Clin Pharmacol Ther 50:663-672.
20. Halliwell B. 1989. Tell me about free radicals, doctor: a review. J R Soc Med 82:747-752. (Pubitemid 20016945)
21. Harrison R. 2002. Structure and function of xanthine oxidoreductase: Where are we now? Free Radic Biol Med 33:774- 797. (Pubitemid 35232313)
22. Harkness RA, McCreanor GM, Simpson D, MacFadyen IR, 1986. Pregnancy in and incidence of xanthine oxidase deficiency. J Inherit Metab Dis 9:407-408. (Pubitemid 17216135)
23. Herken H, Akyol O, Yilmaz HR, Tutkun H, Savas HA, Ozen ME, et al. 2006. Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment. Hum Psychopharmacol 21:53-59. (Pubitemid 43192476)
24. Herken H, Gurel A, Selek S, Armutcu F, Ozen ME, Bulut M et al. 2007. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 38:247-252. (Pubitemid 46080553)
25. Hille R. 2005. Molybdenum-containing hydroxylases. Arch Biochem Biophys 433:107-116. (Pubitemid 39591630)
26. Ichida K, Amaya Y, Noda K, Minoshima S, Hosoya T, Sakai O, et al. 1993. Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): structural analysis of the protein and chromosomal location of the gene. Gene 133:279-284. (Pubitemid 23340917)
27. Ichida K, Amaya Y, Kamatani N, Nishino T, Hosoya T, Sakai O. 1997. Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria. J Clin Invest 99:2391-2397. (Pubitemid 27227716)
28. Ichida K, Yoshida M, Sakuma R, Hosoya T. 1998. Two siblings with classical xanthinuria type 1: significance of allopurinol loading test. Intern Med 37:77-82.
29. Holthoff VA, Beuthien-Baumann B, Zündorf G, Triemer A, Lüdecke S, Winiecki P, et al. 2004. Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatr Scand 110:184-194.
30. Jana A, Pahan K. 2007. Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis. J Neuroimmune Pharmacol 2:184-193.
31. Karabulut AB, Kafkasli A, Burak F, Gozukara EM. 2005. Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia. Cell Biochem Funct 3:279-283.
32. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. 2003. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 8:365-370.
33. Koutsilieri E, Scheller C, Tribl F, Riederer P. 2002. Degeneration of neuronal cells due to oxidative stress-microglial contribution. Parkinsonism Relat Disord 8:401-406.
34. Levartovsky D, Lagziel A, Sperling O, Liberman U, Yaron M, Hosoya T, et al. 2000. XDH gene mutation is the underlying cause of classical xanthinuria: a second report. Kidney Int 57:2215-2220.
35. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the folin phenol reagent. J Biol Chemistry 193:265-276.
36. Lukash AI, Zaika VG, Kucherenko AO, Miliutina NP. 2002. Free radical processes and antioxidant system in depression and treatment efficiency. [Article in Russian] Zh Nevrol Psikhiatr Im S S Korsakova 102:41-44.
37. McCord JM. 1985. Oxygen-derived free radicals in postischemic tissue injury. New Engl J Med 312:159-163.
38. Meyer JH, Ginovart N, Boovariawala A, Sagrati S, Hussey D, Garcia A, et al. 2006. Elevated monoamine oxidase a levels in the brain:an explanation for the monoamine imbalance of major depression. Arch Gen Psychatry 63:1209-1216.
39. Michel TM, Nara K, Camara S, Koutsilieri E, Jecel JCh, Riederer P. 2004a. Activity of xanthine oxidase in different brain regions of patients with Alzheimer's dementia- a post mortem study. World J Biol Psychiatry 5:86.
40. Michel TM, Nara K, Camara S, Koutsilieri E, Thome J, Riederer P. 2004b. Xanthine oxidase activity is decreased in distinct brain areas of patients with schizophrenic psychoses- a post mortem study. World J Biol Psychiatry 5:11.
41. Michel TM, Thome J, Nara K, Martin D, Camara S,Weijers HG, et al. 2004c. The role of oxidative stress in the pathogenesis of schizophrenic psychoses- superoxide dismutase (SOD)-coenzyme con-concentrations in post-mortem brain tissue of schizophrenic patients. J Neural Transm 111:1191-1201.
42. Michel TM, Frangou S, Thiemeyer D, Camara S, Jecel J, Nara K, et al. 2007. Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder- a post-mortem study. Psychiatry Res 151:145-150.
43. Milak MS, Parsey RV, Keilp J, Oquendo MA, Malone KM,Mann J. 2005. Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry 62:397-408.
44. Minoshima S, Wang Y, Ichida K, Nishino T, Shimizu N. 1995. Mapping of the gene for human xanthine dehydrogenase (oxidase) (XDH) to band p23 of chromosome 2. Cytogenet Cell Genet 68:52-53.
45. Murata T, Suzuki R, Higuchi T, Oshima A. 2000. Regional cerebral blood flow in the patients with depressive disorders. Keio J Med 49(Suppl):A112-113.
46. Nishino T. 1994. The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. J Biochem (Tokyo) 116:1-6.
47. Oda K, Okubo Y, Ishida R, Murata Y, Ohta K, Matsuda T, et al. 2003. Regional cerebral blood flow in depressed patients with white matter magnetic resonance hyperintensity. Biol Psychiatry 53:150-156.
48. Parashos IA, Tupler LA, Blitchington T, Krishnan KR. 1998. Magnetic-resonance morphometry in patients with major depression. Psychiatry Res 84:7-15.
49. Petrone WF, English DK, Wong K, McCord JM. 1980. Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma. Proc Natl Acad Sci USA 77:1159-1163.
50. Peet M, Murphy B, Shay J, Horrobin D. 1998. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43:315-319. (Pubitemid 28137622)
51. Riederer P, Lange KW. 1992. Pathogenesis of Parkinson's disease. Curr Opin Neurol Neurosurg 5:295-300.
52. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62.
53. Roy RS, McCord JM. 1983. Oxy Radicals and their scavenger systems. Amsterdam: Elsevier/North Holland.
54. Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, et al. 1989. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 53:692- 697.
55. Sakamoto N, Yamamoto T, Moriwaki Y, Teranishi T, Toyoda M, Onishi Y, et al. 2001. Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type I xanthinuria. Hum Genet 108:279-283.
56. Saksela M, Lapatto R, Raivio KO. 1998. Xanthine oxidoreductase gene expression and enzyme activity in developing human tissues. Biol Neonate 74:274-280.
57. Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. 2007. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 22:67-73.
58. Saruwatari J, Nakagawa K, Shindo J, Tajiri T, Fujieda M, Yamazaki H, et al. 2002. A population phenotyping study of three drug-metabolizing enzymes in Kyushu, Japan, with use of the caffeine test. Clin Pharmacol Ther 72:200-208.
59. Schneider F, Gur RE, Mozley LH, Smith RJ, Mozley PD, Censits DM, et al. 1995. Mood effects on limbic flow correlate with emotional self-rating: a PET study with oxygen-15 labeled water. Psychiatry Res: Neuroimaging 61:265-283.
60. Sheline YI. 2000. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psychiatry 48:791-800.
61. Sheline YI. 2003. Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 54:338-352.
62. Simmonds HA, Reiter S, Nishino T. Hereditary xanthinuria. 1995. In: Scriver CR, Beaudet AL, Sly SW, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-NeHill Inc 1781-1797.
63. Soares JC, Mann JJ. 1997. The anatomy of mood disorders-review of structural neuroimaging studies. Biol Psychiatry 41:86-106. (Pubitemid 27050649)
64. Takano H, Motohashi N, Uema T, Ogawa K, Ohnishi T, Nishikawa M, et al. 2007. Changes in regional cerebral blood flow during acute electroconvulsive therapy in patients with depression: positron emission tomographic study. Br J Psychiatry 190:63-68. (Pubitemid 46121503)
65. Terada LS, Willingham IR, Roasandich ME, Leff JA, Kindt GW, Repine JE. 1991. Generation of superoxide anion by brain endothelial cell xanthine oxidase. J Cell Physiol 148:191-196.
66. Terada LS, Guidot LS, Leff DM, Willingham IR, Hanley ME, Piermattei D, et al. 1992. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proc Natl Acad Sci USA 89:3362-3366.
67. Thome J, Gsell W, Rösler M, Kornhuber J, Frölich L, Hashimoto E, et al. 1997. Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease. Life Sci 60:13-19.
68. Vasic N, Walter H, Höse A, Wolf RC. 2008. Gray matter reduction associated with psychopathology and cognitive dysfunction in unipolar depression: A voxel-based morphometric study. J Affect Disor Epub.
69. Wang JY, Wen LL, Huang YN, Chen YT, Ku MC. 2006. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr Pharm Des 12:3521-3533.
70. Winterbourn CC. 1993. Superoxide as an intracellular radical sink. Free Radic Biol Med 14:85-90.
71. Xu P, Huecksteadt TP, Harrison R, Hoidal JR. 1994a. Molecular cloning, tissue expression of human xanthine dehydrogenase. Biochem Biophys Res Commun 199:998-1004.
72. Xu P, Zhu XL, Huecksteadt TP, Brothman AR, Hoidal JR. 1994b. Assignment of human xanthine dehydrogenase gene to chromosome 2p22. Genomics 23:289-291.
73. Zoroglu SS, Armutcu F, Ozen S, Gurel A, Sivasli E, Yetkin O et al. 2004. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci 54:143-147.
74. Zweier JL, Kuppusamy P, Lutty GA. 1988. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci USA 85:4046-4050.